Home Cart Sign in  
Chemical Structure| 134234-12-1 Chemical Structure| 134234-12-1

Structure of Traxoprodil
CAS No.: 134234-12-1

Chemical Structure| 134234-12-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Traxoprodil a selective antagonist of the NR2B subunit of the NMDA receptor.

Synonyms: CP101,606; CP 98,113; (+)-CP 101,606

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Traxoprodil

CAS No. :134234-12-1
Formula : C20H25NO3
M.W : 327.42
SMILES Code : OC1(C2=CC=CC=C2)CCN([C@@H](C)[C@@H](O)C3=CC=C(O)C=C3)CC1
Synonyms :
CP101,606; CP 98,113; (+)-CP 101,606
MDL No. :MFCD00926469
InChI Key :QEMSVZNTSXPFJA-HNAYVOBHSA-N
Pubchem ID :219101

Safety of Traxoprodil

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317-H319
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00163085 Parkinson's Disease Phase 2 Completed - United States, Oregon ... More >> Pfizer Investigational Site Portland, Oregon, United States, 97239 Less <<
NCT00163059 Depressive Disorder, Major Phase 2 Completed - United States, Kansas ... More >> Pfizer Investigational Site Wichita, Kansas, United States, 67214-2878 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.05mL

0.61mL

0.31mL

15.27mL

3.05mL

1.53mL

30.54mL

6.11mL

3.05mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories